Literature DB >> 16513854

Cognitive behavior therapy for schizophrenia.

Douglas Turkington1, David Kingdon, Peter J Weiden.   

Abstract

OBJECTIVE: A growing body of evidence supports the use of cognitive behavior therapy for the treatment of schizophrenia. A course of cognitive behavior therapy, added to the antipsychotic regimen, is now considered to be an appropriate standard of care in the United Kingdom. The objective of this article is to offer a broad perspective on the subject of cognitive behavior therapy for schizophrenia for the American reader.
METHOD: The authors summarize current practice and data supporting the use of cognitive behavior therapy for schizophrenia.
RESULTS: Five aspects of cognitive behavior therapy for schizophrenia are addressed: 1) evidence from randomized clinical trials, 2) currently accepted core techniques, 3) similarities to and differences from other psychosocial interventions for schizophrenia, 4) differences between the United States and United Kingdom in implementation, and 5) current directions of research.
CONCLUSIONS: The strength of the evidence supporting cognitive behavior therapy for schizophrenia suggests that this technique should have more attention and support in the United States.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513854     DOI: 10.1176/appi.ajp.163.3.365

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

1.  Key stakeholder perceptions regarding acute care psychiatry in distressed publicly funded mental health care markets.

Authors:  B Christopher Frueh; Anouk L Grubaugh; Anthony T Lo Sasso; Walter J Jones; John M Oldham; Richard C Lindrooth
Journal:  Bull Menninger Clin       Date:  2012

2.  Psychological and social interventions for schizophrenia.

Authors:  David Kingdon
Journal:  BMJ       Date:  2006-07-29

3.  The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.

Authors:  Dawn I Velligan; Pamela M Diamond; Jim Mintz; Natalie Maples; Xueying Li; John Zeber; Larry Ereshefsky; Yui-Wing F Lam; Desiree Castillo; Alexander L Miller
Journal:  Schizophr Bull       Date:  2007-10-10       Impact factor: 9.306

Review 4.  Lack of insight in schizophrenia: impact on treatment adherence.

Authors:  Peter F Buckley; Donna A Wirshing; Prameet Bhushan; Joseph M Pierre; Seth A Resnick; William C Wirshing
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Disseminating evidence-based practices for adults with PTSD and severe mental illness in public-sector mental health agencies.

Authors:  B Christopher Frueh; Anouk L Grubaugh; Karen J Cusack; Jon D Elhai
Journal:  Behav Modif       Date:  2008-08-22

6.  Case manager as therapy extender for cognitive behavior therapy of serious mental illness: a case report.

Authors:  Narsimha R Pinninti; Lisa T Schmidt; Richard P Snyder
Journal:  Community Ment Health J       Date:  2013-07-05

7.  What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Authors:  Christoph U Correll; Jose M Rubio; John M Kane
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

8.  [Adherence to psychopharmacological treatment: Psychotherapeutic strategies to enhance adherence].

Authors:  R Lencer; D Korn
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

9.  Cognitive behavior therapy for people with schizophrenia.

Authors:  Ann K Morrison
Journal:  Psychiatry (Edgmont)       Date:  2009-12

10.  Call it a monster for lack of anything else: narrative insight in psychosis.

Authors:  David Roe; Ilanit Hasson-Ohayon; Shlomo Kravetz; Phil T Yanos; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2008-12       Impact factor: 2.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.